All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

colorado-springs

axios-local

axios-pro

axios-live

the-axios-show

Digital care company OneStep raised a $36 million Series B to analyze patients' movement, CEO Tomer Shussman tells Axios exclusively. 

Why it matters: As life expectancy rises, it's increasingly essential to diagnose and manage chronic conditions.

Zoom in: The round was co-led by Team8 and Vintage Investment Partners, with participation from LionBird, Aleph, and 10D.

"We are not cash flow positive but have a responsible net burn," Shussman says.

How it works: OneStep's app Gait uses clinical-grade motion analysis via smartphone sensors to deliver insights about central nervous system, musculoskeletal, and cardiorespiratory functions.

The FDA-listed, AI care platform can help detect neurodegenerative disease and fall risk, using continuous, real-life monitoring.

OneStep sells to health care providers like skilled nursing facilities, outpatient rehabilitation, home care, orthotics and prosthetics. Anyone can download the app for free and record their walks to get insights.

What's next: "We want to continue to expand use cases, as we just started selling to medical device manufacturers," Shussman says. 

He said the current runway is roughly three to four years.

What they're saying: "A lot of times we see companies that are building a product that could have a strong impact, but it requires too much of a change in the clinician's workflow, or it's hard to put into the hands of patients," says Team8 investor Asaf Charnilas.

"And here you have something that doesn't really change the way that they work in the workflow sense, so it's easy for them to adopt," as the data is transmitted directly to the clinician portal for review.

Exclusive: OneStep snags $36M for smartphone gait motion analysis

It's increasingly essential to diagnose chronic conditions.

Illustration of a phone wearing a doctor's coat and a stethoscope. 

Health tech deals

Digital care company OneStep raised a $36 million Series B to analyze patients&#x27; movement, CEO Tomer Shussman tells Axios exclusively. Why it matters: As <a class="gtmContentClick" data-vars-link-text="life expectancy rises" data-vars-click-url="https://www.axios.com/2024/10/09/us-health-obesity-life-expectancy" data-vars-content-id="e96a8d21-2105-49bf-865c-e548a4a6b05d" data-vars-headline="Exclusive: OneStep snags $36M for smartphone gait motion analysis" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/2024/10/09/us-health-obesity-life-expectancy" target="_self">life expectancy rises</a>, it&#x27;s increasingly essential to diagnose and manage chronic conditions.

Exclusive: OneStep snags $36M for smartphone gait motion analysis

What to read next